miRNAs; a novel strategy for the treatment of COVID‐19

H Ying, M Ebrahimi, M Keivan… - Cell biology …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …
被引用次数：72 相关文章

miRNAs; a novel strategy for the treatment of COVID-19.

H Ying, M Ebrahimi, M Keivan… - Cell Biology …, 2021 - europepmc.org
Abstract Coronavirus disease 2019 (COVID‐19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …

miRNAs; a novel strategy for the treatment of COVID-19.

H Ying, M Ebrahimi, M Keivan, SE Khoshnam, S Salahi… - 2021 - cabidigitallibrary.org
Abstract Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell …

miRNAs; a novel strategy for the treatment of COVID‐19.

H Ying, M Ebrahimi, M Keivan… - Cell Biology …, 2021 - search.ebscohost.com
Abstract Coronavirus disease 2019 (COVID‐19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …
[HTML] nih.gov

[HTML][HTML] miRNAs; a novel strategy for the treatment of COVID‐19

H Ying, M Ebrahimi, M Keivan… - Cell Biology …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID‐19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …

miRNAs; a novel strategy for the treatment of COVID-19

H Ying, M Ebrahimi, M Keivan… - Cell biology …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute
respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell …